Novel surgical approach for intraventricular cerliponase alfa enzyme replacement therapy via central venous access device (CVAD) port in neuronal ceroid lipofuscinosis type 2 (CLN2) disease. [PDF]
Boop S +8 more
europepmc +1 more source
Conversion of a ventricular rickham reservoir to a subcutaneous chest port for repeated intraventricular enzyme replacement therapy: technical note and surgical considerations. [PDF]
Gopalka M +5 more
europepmc +1 more source
Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease. [PDF]
Whiting REH +5 more
europepmc +1 more source
CLN2 Batten disease diagnosed via newborn genome screening
Patrick O’Connell +6 more
openaire +1 more source
Psychiatric manifestations in Neuronal ceroid lipofuscinoses. [PDF]
Della Vecchia S +5 more
europepmc +1 more source
PPARα and RXRα in the regulation of neuronal ceroid lipofuscinosis genes: implications for Batten disease therapy. [PDF]
Chandra S, Pahan K.
europepmc +1 more source
Caregiver Reports of Neurodevelopmental Functions in Pediatric Lysosomal Storage Disorders: A Scoping Review. [PDF]
Gillan EM +4 more
europepmc +1 more source
Patient Perspective-Where Does the Value for Money of a Treatment Really Lie? [PDF]
Mathieson TA +3 more
europepmc +1 more source

